LPL Financial’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,605
| Closed | -$23.4K | – | 4831 |
|
|
2023
Q2 | $23.4K | Sell |
10,605
-41,345
| -80% | -$85.7K | ﹤0.01% | 4504 |
|
|
2023
Q1 | $132K | Buy |
51,950
+10,000
| +24% | +$19.8K | ﹤0.01% | 4150 |
|
|
2022
Q4 | $78.4K | Hold |
41,950
| – | – | ﹤0.01% | 4214 |
|
|
2022
Q3 | $108K | Hold |
41,950
| – | – | ﹤0.01% | 4092 |
|
|
2022
Q2 | $81K | Buy |
41,950
+9,400
| +29% | +$20.5K | ﹤0.01% | 4164 |
|
|
2022
Q1 | $97K | Sell |
32,550
-56,780
| -64% | -$214K | ﹤0.01% | 3982 |
|
|
2021
Q4 | $401K | Sell |
89,330
-14,150
| -14% | -$67.1K | ﹤0.01% | 3465 |
|
|
2021
Q3 | $503K | Buy |
103,480
+10,771
| +12% | +$59.4K | ﹤0.01% | 3204 |
|
|
2021
Q2 | $632K | Buy |
92,709
+1,580
| +2% | +$12.8K | ﹤0.01% | 2953 |
|
|
2021
Q1 | $643K | Sell |
91,129
-3,256
| -3% | -$23.4K | ﹤0.01% | 2809 |
|
|
2020
Q4 | $591K | Sell |
94,385
-2,890
| -3% | -$17K | ﹤0.01% | 2605 |
|
|
2020
Q3 | $526K | Sell |
97,275
-8,700
| -8% | -$43.1K | ﹤0.01% | 2416 |
|
|
2020
Q2 | $553K | Sell |
105,975
-1,000
| -0.9% | -$4.44K | ﹤0.01% | 2305 |
|
|
2020
Q1 | $337K | Buy |
106,975
+4,512
| +4% | +$16.6K | ﹤0.01% | 2401 |
|
|
2019
Q4 | $413K | Buy |
102,463
+29,050
| +40% | +$101K | ﹤0.01% | 2531 |
|
|
2019
Q3 | $317K | Buy |
73,413
+13,350
| +22% | +$53.4K | ﹤0.01% | 2635 |
|
|
2019
Q2 | $240K | Buy |
60,063
+2,100
| +4% | +$9.99K | ﹤0.01% | 2891 |
|
|
2019
Q1 | $311K | Buy |
57,963
+4,788
| +9% | +$30.9K | ﹤0.01% | 2599 |
|
|
2018
Q4 | $273K | Sell |
53,175
-1,975
| -4% | -$15K | ﹤0.01% | 2540 |
|
|
2018
Q3 | $535K | Buy |
55,150
+4,725
| +9% | +$47.7K | ﹤0.01% | 2175 |
|
|
2018
Q2 | $514K | Sell |
50,425
-500
| -1% | -$5.66K | ﹤0.01% | 2173 |
|
|
2018
Q1 | $662K | Buy |
50,925
+6,350
| +14% | +$94.5K | ﹤0.01% | 1911 |
|
|
2017
Q4 | $798K | Buy |
44,575
+5,125
| +13% | +$107K | ﹤0.01% | 1701 |
|
|
2017
Q3 | $990K | Buy |
39,450
+10,200
| +35% | +$237K | ﹤0.01% | 1435 |
|
|
2017
Q2 | $705K | Sell |
29,250
-500
| -2% | -$11.1K | ﹤0.01% | 1622 |
|
|
2017
Q1 | $553K | Buy |
29,750
+300
| +1% | +$4.73K | ﹤0.01% | 1717 |
|
|
2016
Q4 | $459K | Hold |
29,450
| – | – | ﹤0.01% | 1818 |
|
|
2016
Q3 | $403K | Buy |
29,450
+3,000
| +11% | +$39.8K | ﹤0.01% | 1904 |
|
|
2016
Q2 | $351K | Buy |
26,450
+450
| +2% | +$6.63K | ﹤0.01% | 1958 |
|
|
2016
Q1 | $388K | Buy |
+26,000
| New | +$398K | ﹤0.01% | 2339 |
|
LPL Financial's PRTK Position: Q3 2023 in Review
LPL Financial sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 10,605 shares — an estimated $23.4K sold.
LPL Financial first reported a position in PRTK in Q1 2016 and held it in 30 quarters. The position peaked at $990K in Q3 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- LPL Financial reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- LPL Financial sold 10,605 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $23.4K.
- LPL Financial first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2016 and held it in 30 quarters.
- LPL Financial's Paratek Pharmaceuticals, Inc. position peaked at $990K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on LPL Financial's 13F filing for Q3 2023, filed 13 Nov 2023.